Project Grant R42HL170864
Award Date
9/17/24
Completion Date
4/16/25
Dollars Obligated
$294K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Cambridge, MA 02139, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), provides $306,643 to develop a new extracorporeal membrane oxygenation (ECMO) pump designed for low-flow rates required for pediatric and neonatal patients. The primary objectives are to 1) design, develop, and bench test a pump that can operate in the 0.05 to 0.5 L/min flow rate range, which is an order of magnitude lower than...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,160,157 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to Liberandum Technologies, Inc. in San Francisco, CA. The goal of this Phase I Small Business Innovation Research (SBIR) project is to develop and test a bidirectional synchronous flow-controlled ventilation system to improve oxygenation and ventilation in patients with acute respiratory distress syndrome (ARDS). The ventilation system aims to provide gentle...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $275,396 to Link Biosystems Inc., a self-certified small disadvantaged business, to develop bioreactor technologies for efficient differentiation, scale-up, and maturation of induced pluripotent stem cell (iPSC)-derived cardiomyocytes. The research aims to address challenges in producing clinically relevant quantities of...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $295,924 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Convergent Engineering, Inc. to develop a prototype decision support system for personalizing mechanical ventilation care. The proposed system aims to simplify the use of esophageal pressure measurements and provide decision support to optimize ventilator settings and prevent complications for ventilated patients. Key objectives include...
Functional Fluidics Inc., a minority-owned small business based in Detroit, Michigan, was awarded a $265,347 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) to develop a point-of-care diagnostic system for assessing red blood cell sickling in patients with sickle cell disease. The goal of this Phase I project is to create a rapid, integrated test that can be used as a research tool to assist...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports the "Preclinical Evaluation of a Peptide-Amphiphile Derived Toroidal Oxygen Carrier" research project. The $715,110 award, effective February 1, 2025, aims to design and optimize a blood substitute prototype (nano-RBC/nRBC) based on a deformable nanoparticle that is morphologically similar to red blood cells and incorporates high per-particle...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a modern Electrical Impedance Tomography (EIT) device for monitoring children in the Intensive Care Unit (ICU). The $299,900 award to Goodlife Inventors LLC will fund efforts to (1) generate initial designs for an advanced lightweight EIT belt and (2) assess the technical feasibility of a miniaturized, easier to use EIT core device. If...
This $163,760 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports research at Tufts Medical Center to investigate how the use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) impacts ventricular-arterial coupling and myocardial injury in patients with acute myocardial infarction and cardiogenic shock. The 5-year project aims to 1) determine how VA-ECMO alters...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $498,991.40 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Arkansas. The grant, with a period of performance from January 2, 2025 to December 31, 2027, will support research to develop microphysiological systems that can precisely control oxygen levels to investigate the molecular pathways and functional effects of hypoxic injury on cardiomyocytes. The research aims to obtain a...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $299,995 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to Nanite Inc., a small disadvantaged business in Massachusetts. The grant will fund the development of computationally-designed polymer-based delivery vehicles for mRNA payloads to treat cystic fibrosis (CF), a debilitating genetic disorder affecting the lungs. The project aims to leverage computational modeling and high-throughput polymer...